Flagship Harbor Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Flagship Harbor Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,281	Closed	-$7K	–	1992
2020 Q3	$7K	Buy	3,281 +200	+6%	+$571	﹤0.01%	1463
2020 Q2	$11K	Hold	3,081	–	–	﹤0.01%	1342
2020 Q1	$12K	Hold	3,081	–	–	﹤0.01%	1183
2019 Q4	$9K	Buy	+3,081	New	+$8.01K	﹤0.01%	1385

Other funds holding BMY.RT

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return